학술논문

Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial
Document Type
Journal
Source
LANCET; NOV 12 2022, 400 10364, p1704-p1711, 8p.
Subject
Language
English
ISSN
1474547X